AAMRXAmneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (AMRX) is a public company in the healthcare sector. Its common stock trade on NASDAQ.

Over the trailing twelve months as reported to 2025-12-31, revenue was 3.0bn $, net income was 72.1m $.

This summary is compiled automatically from SEC filings and exchange data.